SPARC	NNP
suppresses	VBZ
apoptosis	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
fibroblasts	NNS
through	IN
constitutive	JJ
activation	NN
of	IN
beta-catenin	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
poorly	RB
understood	VBN
progressive	JJ
disease	NN
characterized	VBN
by	IN
the	DT
accumulation	NN
of	IN
scar	NN
tissue	NN
in	IN
the	DT
lung	NN
interstitium	NN
.	.

A	DT
hallmark	NN
of	IN
the	DT
disease	NN
is	VBZ
areas	NNS
of	IN
injury	NN
to	TO
type	NN
II	CD
alveolar	JJ
epithelial	JJ
cells	NNS
with	IN
attendant	JJ
accumulation	NN
of	IN
fibroblasts	NNS
in	IN
areas	NNS
called	VBN
fibroblastic	JJ
foci	NNS
.	.

In	IN
an	DT
effort	NN
to	TO
better	RB
characterize	VB
the	DT
lung	NN
fibroblast	NN
phenotype	NN
in	IN
IPF	NN
patients	NNS
,	,
we	PRP
isolated	VBD
fibroblasts	NNS
from	IN
patients	NNS
with	IN
IPF	NN
and	CC
looked	VBD
for	IN
activation	NN
of	IN
signaling	NN
proteins	NNS
,	,
which	WDT
could	MD
help	VB
explain	VB
the	DT
exaggerated	JJ
fibrogenic	JJ
response	NN
in	IN
IPF	NN
.	.

We	PRP
found	VBD
that	IN
IPF	NN
fibroblasts	NNS
constitutively	RB
expressed	VBD
increased	VBN
basal	JJ
levels	NNS
of	IN
SPARC	NNP
,	,
plasminogen-activator-inhibitor-1	NN
(	(
PAI-1	NN
)	)
,	,
and	CC
active	JJ
beta-catenin	NN
compared	VBN
with	IN
control	NN
cells	NNS
.	.

Control	NN
of	IN
basal	JJ
PAI-1	NN
expression	NN
in	IN
IPF	NN
fibroblasts	NNS
was	VBD
regulated	VBN
by	IN
SPARC-mediated	JJ
activation	NN
of	IN
Akt	NN
,	,
leading	VBG
to	TO
inhibition	NN
of	IN
glycogen	NN
synthase	NN
kinase-3beta	NN
and	CC
activation	NN
of	IN
beta-catenin	NN
.	.

Additionally	RB
,	,
IPF	NN
fibroblasts	NNS
(	(
but	CC
not	RB
control	JJ
fibroblasts	NNS
)	)
were	VBD
resistant	JJ
to	TO
plasminogen-induced	JJ
apoptosis	NN
and	CC
were	VBD
sensitized	VBN
to	TO
plasminogen-mediated	JJ
apoptosis	NN
by	IN
inhibition	NN
of	IN
SPARC	NNP
or	CC
beta-catenin	NN
.	.

These	DT
findings	NNS
uncover	VBP
a	DT
newly	RB
discovered	VBN
regulatory	JJ
pathway	NN
in	IN
IPF	NN
fibroblasts	NNS
that	WDT
is	VBZ
characterized	VBN
by	IN
elevated	JJ
SPARC	NNP
,	,
giving	VBG
rise	NN
to	TO
activated	VBN
beta-catenin	NN
,	,
which	WDT
regulates	VBZ
expression	NN
of	IN
downstream	JJ
genes	NNS
,	,
such	JJ
as	IN
PAI-1	NN
,	,
and	CC
confers	VBZ
an	DT
apoptosis-resistant	JJ
phenotype	NN
.	.

Disruption	NN
of	IN
this	DT
pathway	NN
may	MD
represent	VB
a	DT
novel	JJ
therapeutic	JJ
target	NN
in	IN
IPF	NN
.	.

